Login

Delisting Not on the Agenda" | Francis Van Eeckhout (Deceuninck) | CEO Talk | Francis Van Eeckhout - CEO of Deceuninck 00:10:00

Share On Facebook Share On Twitter

Francis Van Eeckhout is Chairman/Interim CEO at Deceuninck.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
David Cataford, CEO of Champion Iron, on Canadian Iron Ore and Industry Safety | David Cataford, CEO , Champion Iron Ltd.
00:10:00
Unmasking the Pitfalls: How Media Impacts Investor Decisions
00:10:00
Balancing the Basket: Mandeep Singh on Diversification Strategies | Mandeep Singh – Investment Strategist, BlackRock UK
00:10:00
From Concert Pianist to Financial Planner: Sarah Kang's Journey and Insights | Sarah Kang, Certified Financial Planner of UAK Diversified Wealth Advisors
00:10:00
Steven Kobos, President & CEO of Excelerate Energy, discusses the company's decision to go public, highlighting the strategic growth opportunities in floating storage and regasification units (FSRUs).
00:10:00
Pegasystems Inc. founder and CEO, Alan Trefler, discussed company insights with Dave Vellante, host of theCUBE, SiliconANGLE Media.|Alan Trefler is the Founder and CEO of Pegasystems Inc.,
00:10:00
Insights from Ariel Investments' Co-CEO on Market Strategies
00:10:00
Evli Fund Management Company Ltd. is a financial services firm specializing in asset management and investment solutions.
00:10:00
Interview with Ed Clarke, CEO of Yojee Ltd | Ed Clarke, CEO, Yojee LtdYOJ:ASX
00:10:00
Liam Dalton, founder and chairman of Axiom Capital, discusses inflation and its ongoing challenges in light of President Biden's remarks.
00:10:00
Atlas Copco CEO on Energy Efficiency and Climate Action | Mats Rahmström, President, Atlas Copco Group.
00:10:00
Client Concerns in 2024: Portfolio Strategies and Market Trends | Hanneke Smits, CEO , The Bank of New York Mellon Corporation.

© 2017 - Neuhu+